4/A: Omada Health Director Corrects RSU Holdings

Omada Health Director Jeryl L. Hilleman filed an amended Form 4 to correct an overstatement of 45 restricted stock units in a previous filing.

Summary

• Jeryl L. Hilleman, a Director at Omada Health, Inc., filed an amended Form 4/A.
• The amendment corrects an error in the original Form 4 filed on 10/07/2025.
• The original filing inadvertently overstated the amount of securities acquired and beneficially owned by 45 shares.
• The corrected transaction on 10/05/2025 involved the acquisition of 1,081 Restricted Stock Units (RSUs).
• These RSUs were granted under the Issuer's Non-Employee Director Compensation Program in lieu of retainer fees.
• Following the corrected transaction, Jeryl L. Hilleman beneficially owns 11,193 shares of Common Stock.

Sentiment

Score: 5

Explanation: The filing is an administrative correction of a previous insider transaction report and does not reflect on the company's operational or financial performance, thus indicating a neutral sentiment.

Positives

• The company and director demonstrated transparency by promptly correcting an administrative error in a public filing.

Negatives

• An initial error in reporting required an amendment to a previously filed Form 4.

Related Party Transactions

• Grant of 1,081 Restricted Stock Units (RSUs) to Director Jeryl L. Hilleman as part of the Non-Employee Director Compensation Program, in lieu of retainer fees.

Stakeholder Impact

• Shareholders receive corrected and accurate information regarding a director's beneficial ownership, ensuring regulatory compliance and transparency.

Next Steps

• Settlement of the Restricted Stock Units (RSUs) will occur on a date selected by the Reporting Person or as otherwise provided by the Non-Employee Director Compensation Program.

Key Dates

Recommendation

This filing is an administrative correction of an insider transaction and provides no new information regarding the company's financial performance, strategic direction, or operational health that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as there are no new fundamental drivers presented.

Keywords

Omada Health, OMDA, SEC Form 4/A, insider transaction, restricted stock units, RSU, director compensation, beneficial ownership amendment